Terms: = Head and neck cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3 AND Treatment
36807 results:
1. Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study.
Zhang C; Lan Q; Wei P; Gao Y; Zhang J; Hua H
BMC Oral Health; 2024 May; 24(1):639. PubMed ID: 38816724
[TBL] [Abstract] [Full Text] [Related]
2. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
Li S; Liu Z; Chen Q; Chen Y; Ji S
Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
[TBL] [Abstract] [Full Text] [Related]
3. Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer.
Chen CS; Luo SD; Chang YH; Chou CK; Chi SY; Wu SC; Chen YH; Yang JC; Huang EY; Wang YM; Lin WC
Int J Hyperthermia; 2024; 41(1):2358054. PubMed ID: 38816274
[TBL] [Abstract] [Full Text] [Related]
4. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma.
Wang Z; Ji X; Zhang Y; Yang F; Su H; Zhang H; Li Z; Zhang W; Sun W
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816233
[TBL] [Abstract] [Full Text] [Related]
5. Surgical and multimodal treatment of metastatic oesophageal cancer: retrospective cohort study.
Knipper K; Lemties J; Krey T; Lyu SI; Wirsik NM; Schiffmann LM; Fuchs HF; Gebauer F; Schröder W; Popp FC; Quaas A; Schlößer HA; Bruns CJ; Schmidt T
BJS Open; 2024 May; 8(3):. PubMed ID: 38814750
[TBL] [Abstract] [Full Text] [Related]
6. Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.
Yang X; Zheng X; Hu S; Huang J; Zhang M; Huang P; Wang J
BMC Cancer; 2024 May; 24(1):654. PubMed ID: 38811891
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
Agurto MG; Carpenter GH; Bozorgi SS; Koller G; Fenlon M; Warburton F; Bruce K; Burke M; Banerjee A
BMC Oral Health; 2024 May; 24(1):630. PubMed ID: 38811865
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of the Dosimetric Index from IMRT and Rapid arc Plan for Oropharyngeal cancer with Simultaneous Integrated Boost (SIB) Technique in Combination with EUD-based NTCP and TCP Radiobiological Models.
Dashnamoorthy S; Jeyasingh E; Rajamanickam K; Ahmed I
Asian Pac J Cancer Prev; 2024 May; 25(5):1515-1528. PubMed ID: 38809623
[TBL] [Abstract] [Full Text] [Related]
9. Deep Learning-Based Prediction of Radiation Therapy Dose Distributions in Nasopharyngeal Carcinomas: A Preliminary Study Incorporating Multiple Features Including Images, Structures, and Dosimetry.
Wang Y; Piao Z; Gu H; Chen M; Zhang D; Zhu J
Technol Cancer Res Treat; 2024; 23():15330338241256594. PubMed ID: 38808514
[No Abstract] [Full Text] [Related]
10. Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma.
Chen P; Fu C; Shen L; Fei Z; Luo M; Chen Y; Li H
BMC Health Serv Res; 2024 May; 24(1):676. PubMed ID: 38807104
[TBL] [Abstract] [Full Text] [Related]
11. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive analysis revealed P4Hs as new biomarkers for prognosis and immunotherapy in head and neck cancer.
Zhou H; Lei Y; Luo J; Wang J; Peng L; Mou K; Xiang L; Luo Y
Sci Rep; 2024 May; 14(1):12234. PubMed ID: 38806556
[TBL] [Abstract] [Full Text] [Related]
13. Donafenib as neoadjuvant therapy in locally advanced thyroid cancer: protocol for the DONATHYCA phase II prospective single-arm trial in China.
Yu J; Liu H; Wu Y
BMJ Open; 2024 May; 14(5):e081090. PubMed ID: 38806431
[TBL] [Abstract] [Full Text] [Related]
14. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
Qiu MZ; Oh DY; Kato K; Arkenau T; Tabernero J; Correa MC; Zimina AV; Bai Y; Shi J; Lee KW; Wang J; Poddubskaya E; Pan H; Rha SY; Zhang R; Hirano H; Spigel D; Yamaguchi K; Chao Y; Wyrwicz L; Disel U; Cid RP; Fornaro L; Evesque L; Wang H; Xu Y; Li J; Sheng T; Yang S; Li L; Moehler M; Xu RH;
BMJ; 2024 May; 385():e078876. PubMed ID: 38806195
[TBL] [Abstract] [Full Text] [Related]
15. [Our experience in the treatment of congenital nasal median heterotopias in children and an overview of various treatment tactics].
Molodtsova EV; Yunusov AS; Daikhes NA; Polyakov DP; Korobkin AS; Larina OM
Vestn Otorinolaringol; 2024; 89(2):28-32. PubMed ID: 38805460
[TBL] [Abstract] [Full Text] [Related]
16. Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.
Mou Y; Liang P; Cheng X; He X; Zhang J; Liu L; Liu Q
BMC Cancer; 2024 May; 24(1):646. PubMed ID: 38802765
[TBL] [Abstract] [Full Text] [Related]
17. Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries.
Vitale A; Caggiano V; Tufan A; Ragab G; Batu ED; Portincasa P; Aragona E; Sota J; Conti G; De Paulis A; Rigante D; Olivieri AN; Şahin A; La Torre F; Lopalco G; Cattalini M; Maggio MC; Insalaco A; Sfikakis PP; Verrecchia E; Yildirim D; Kucuk H; Kardas RC; Laymouna AH; Ghanema M; Saad MA; Sener S; Ercan Emreol H; Ozen S; Jaber N; Khalil M; Di Ciaula A; Gaggiano C; Malizia G; Affronti A; Patroniti S; Romeo M; Sbalchiero J; Della Casa F; Mormile I; Silvaroli S; Gicchino MF; Çelik NÇ; Tarsia M; Karamanakos A; Hernández-Rodríguez J; Parronchi P; Opris-Belinski D; Barone P; Recke A; Costi S; Sfriso P; Giardini HAM; Gentileschi S; Wiesik-Szewczyk E; Vasi I; Loconte R; Jahnz-Różyk K; Martín-Nares E; Torres-Ruiz J; Cauli A; Conforti A; Emmi G; Li Gobbi F; Biasi GR; Terribili R; Ruscitti P; Del Giudice E; Tharwat S; Brucato AL; Ogunjimi B; Hinojosa-Azaola A; Balistreri A; Fabiani C; Frediani B; Cantarini L
Front Immunol; 2024; 15():1397890. PubMed ID: 38799474
[TBL] [Abstract] [Full Text] [Related]
18. Clinical and Paraclinical Considerations Regarding ki67's Role in the Management of Differentiated Thyroid Carcinoma-A Literature Review.
Peștean C; Pavel A; Piciu D
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792952
[No Abstract] [Full Text] [Related]
19. cancer-associated stroke from progressive acinic cell carcinoma.
Garcia JJB; Pascual JLV
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38789271
[TBL] [Abstract] [Full Text] [Related]
20. Updates in Translational Science for Esophageal and Gastric cancers.
Hompe ED; Sachdeva UM
Surg Oncol Clin N Am; 2024 Jul; 33(3):571-581. PubMed ID: 38789199
[TBL] [Abstract] [Full Text] [Related]
[Next]